Appropriate Duration of Anti-Platelet straTegy in Patients With Advance Chronic Kidney Disease After New Generation Drug Eluting Stents (ADAPT-CKD)

NCT04708587 · clinicaltrials.gov ↗

NA

Phase

RECRUITING

Status

900

Enrollment

OTHER

Sponsor class

Conditions

Chronic Kidney Diseases

Interventions

DRUG: dual anti-platelet therapy at least 6 months
DRUG: dual anti-platelet therapy 3months or less

Sponsor

Yonsei University